Skip to main content

EDITORIAL article

Front. Allergy, 10 October 2024
Sec. Rhinology
This article is part of the Research Topic The Current Role of Allergy in Otolaryngological Disorders View all 5 articles

Editorial: The current role of allergy in otolaryngological disorders

  • 1Department of Otorhinolaryngology, Academic Hospital “Santa Maria della Misericordia”, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy
  • 2Otolaryngology Department, Hospital Universitario Marques de Valdecilla, Santander, Spain
  • 3Valdecilla Biomedical Research Institute, IDIVAL, Santander, Spain
  • 4Otolaryngology Unit, Department of Health Sciences, Santi Paolo e Carlo Hospital, Università Degli Studi di Milano, Milan, Italy
  • 5Immunology Section, Department of Medicine (DAME), University of Udine, Udine, Italy

Editorial on the Research Topic
The current role of allergy in otolaryngological disorders

Historically, Otorhinolaryngology has been closely linked with the immune system since its inception. Surgically treated disorders of the mucosal-associated lymphoid tissue (MALT, in the form of palatine tonsils and adenoids), or the sinonasal microenvironment (presenting as CRS, chronic rhinosinusitis with and without nasal polyps) are in truth immunopathological conditions (1, 2). It is well accepted that procedures such as adenotonsillectomy or endoscopic sinus surgery will still be widely performed in the future. At the same time, our understanding of the interplays between the immune system and the ear, nose, and throat continues to deepen with advances in molecular biology. For example, recent research has identified a subset of peptidase inhibitor 16 (PI16)-expressing fibroblastic reticular cells (FRCs) in human tonsils (3). The population of PI16-FRCs is not present in the pediatric patients and it increases in the aging process; it was shown that this is the cellular subset that undergoes the most profound remodeling as it shapes the tonsillar microenvironment for efficient lymphocyte activation and differentiation (3).

As Editors of the Research Topic “The Current Role of Allergy in Otolaryngological Disorders”, published in the present Journal, we have the privilege of presenting several insightful manuscripts that shed new light on the subject. A notable study by Barreto et al. have used a longitudinal cohort of poly-sensitized children with seasonal allergic rhinitis (AR), in order to identify the allergen most likely to be used in nasal provocation testing (NPT). Determining the exact inflammatory trigger is important to maximize the efficacy of allergen immunotherapy (AIT). The authors have therefore analyzed an extensive amount of clinical and patient-reported data, including those collected by an e-diary smartphone application. After applying logistic regression, they discovered that a combination index of specific IgE activity towards Phl p 5 and Cyn d 1 could predict positive NPT results to grass pollen (area under the curve: 0.82; p < 0.01; best cut-off ≥7.25%, sensitivity 70.5%, specificity: 90.9%). These predictive methods are important because they let us optimize time and resources in the work-up and management of our patients.

De Carli et al. provided a comprehensive and in-depth review of the molecular mechanisms underlying AR, with a particular focus on sex-related differences. For example, females affected by AR appear to exhibit higher levels of IL-4 and IL-13 than males, and these cytokines are indicative of a classical type-2 phenotype. Yet females show a lower abundance of eosinophils in nasal fluids, and these cells are the hallmark of T2-inflammation. Despite this emerging evidence, the relationship between AR and CRS remains complex and somewhat ambiguous, with AR now recognized as a potential risk factor only for certain subtypes of CRS. Finally, the potential role of AIT in the prevention of future development of CRS and asthma is another area of active investigation, with the impact of sexual dimorphism still to be fully explored.

Kumar et al. at the Mayo Clinic have conducted a systematic review examining the role of viruses in the pathogenesis of CRS. While rhinoviruses (among other species) are well-known causes of acute rhinosinusitis, emerging preclinical and clinical data suggest these pathogens may also contribute to the initiation, exacerbation, and persistence of CRS-related immune dysregulation. Some viruses may drive the inflammatory response —particularly in genetically susceptible individuals— toward type 2 phenotypes, and ultimately lead to the development of nasal polyps. If further validated, this theory could have significant therapeutic implications for CRS treatment and prevention.

As a last contribution, Wang et al. used robust genetic methods, including Mendelian randomization analysis and linkage disequilibrium score, in order to investigate possible causal associations between autoimmune disorders and CRS. By exploiting large genome-wide association study data from several databases, they found a significant relationship between CRS and various autoimmune diseases, including AR and asthma, but also with rheumatoid arthritis or immune-mediated hypothyroidism or type 1 diabetes mellitus. Furthermore, the authors found some loci in three chromosomes to be commonly associated with these conditions. Their findings support the notion that a shared genetic predisposition may underlie the persistence of these disorders, independently of the initial trigger.

In conclusion, the topic of the immunological mechanisms of many ear, nose, and throat disorders is far to be fully explored but the future looks promising. The availability of personalized molecular testing is soon to revolutionize our approach to CRS or tonsillitis. Moreover, while current treatments often rely on symptomatic and long-term therapies (e.g., intranasal topical steroids), the advent of monoclonal antibodies is beginning to shift this paradigm, especially for CRS with nasal polyps. As we continue to explore the fundamental immunopathological mechanisms of otolaryngological disorders, achieving rapid clinical remission and potentially discovering effective cures for these conditions may soon become a reality.

Author contributions

LL: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. DL: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. AS: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. CP: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Donovan R, Soothill JF. Immunological studies in children undergoing tonsillectomy. Clin Exp Immunol. (1973) 14(3):347–57.4199090

PubMed Abstract | Google Scholar

2. Kato A, Schleimer RP, Bleier BS. Mechanisms and pathogenesis of chronic rhinosinusitis. J Allergy Clin Immunol. (2022) 149(5):1491–503. doi: 10.1016/j.jaci.2022.02.016

PubMed Abstract | Crossref Full Text | Google Scholar

3. De Martin A, Stanossek Y, Lütge M, Cadosch N, Onder L, Cheng HW, et al. PI16+ reticular cells in human palatine tonsils govern T cell activity in distinct subepithelial niches. Nat Immunol. (2023) 24(7):1138–48. doi: 10.1038/s41590-023-01502-4

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: sinusitis, allergy, rhinology, immunology, otorhinolarygology

Citation: Locatello LG, Lobo D, Saibene AM and Pucillo C (2024) Editorial: The current role of allergy in otolaryngological disorders. Front. Allergy 5:1498340. doi: 10.3389/falgy.2024.1498340

Received: 18 September 2024; Accepted: 30 September 2024;
Published: 10 October 2024.

Edited and Reviewed by: Glenis Kathleen Scadding, University College London, United Kingdom

Copyright: © 2024 Locatello, Lobo, Saibene and Pucillo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Luca Giovanni Locatello, bG9jYXRlbGxvLmx1Y2FnaW92YW5uaUBnbWFpbC5jb20=

ORCID:
Luca Giovanni Locatello
orcid.org/0000-0002-1879-5580

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.